Korrektur
Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”
Drug Development Research · 2026-11 · 87 (7)
DOI: 10.1002/ddr.70393 ↗Kurz gefasst
Korrektur in der Zeitschrift Drug Development Research, online erschienen am 11.10.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70393
Vancouver
Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70393
BibTeX
@article{euvimed2026,
title = {Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {7},
doi = {10.1002/ddr.70393}
}
EUVIMED